VZ
39
2
NKE
36
6
UA
38
3
MTB
75
2
ZTS
25
2
ALL
61
-2
GWW
65
3
PEG
50
4
AZO
46
-2
EXPD
48
-2
CPB
37
2
COST
53
5
VTR
70
3
PVH
30
2
BLK
61
-2
PM
56
2
MSI
47
-2
EXR
26
2
SLG
37
6
HOG
38
2
VZ
39
2
NKE
36
6
UA
38
3
MTB
75
2
ZTS
25
2
ALL
61
-2
GWW
65
3
PEG
50
4
AZO
46
-2
EXPD
48
-2
CPB
37
2
COST
53
5
VTR
70
3
PVH
30
2
BLK
61
-2
PM
56
2
MSI
47
-2
EXR
26
2
SLG
37
6
HOG
38
2
Financhill
Back

FactSet Research Systems, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
42

FDS
FactSet Research Systems, Inc.

Last Price:
$292.07
Seasonality Move:
1.5%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
42
FactSet Research Systems, Inc. (FDS) is a Sell

Is FactSet Research Systems, Inc. a Buy, Sell or Hold?

  • The current FactSet Research Systems, Inc. [FDS] share price is $290.09. The Score for FDS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • FDS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FDS Stock Price Chart

What is FactSet Research Systems, Inc.'s stock price today?

  • The FactSet Research Systems, Inc. share price today is $290.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDS is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

FDS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.98 Buy
Relative Strength Index (14 RSI): 54.55 Buy
Chaikin Money Flow: -20383 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (275.48 - 291.56) Buy
Bollinger Bands (100): (266.08 - 353.12) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

FDS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 289.38 Buy
20-day SMA: 286.02 Buy
50-day SMA: 279.55 Buy
200-day SMA: 372.74 Sell
8-day EMA: 289.05 Buy
20-day EMA: 286.08 Buy
50-day EMA: 288.98 Buy
200-day EMA: 352.68 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

FactSet Research Systems, Inc. Earnings Growth & FDS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.78 per share, and an increase next year of $0.41 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

FactSet Research Systems, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):